Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...
Sigachi Industries is a constituent of BSE Smallcap index. It is engaged in the manufacturing of Microcrystalline Cellulose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback